Crossmark

Albumin-based cancer therapeutics for intraperitoneal drug delivery: a review

Published Online: 2019-12-20

Published Print: 2020-01

Authors

Van de Sande, Leen https://orcid.org/0000-0003-0006-8104
Cosyns, Sarah https://orcid.org/0000-0002-5173-4296
Willaert, Wouter https://orcid.org/0000-0002-0885-6749
Ceelen, Wim https://orcid.org/0000-0001-7692-4419
Funding

Funding for this research was provided by:

Kom op tegen Kanker (Stand up to Cancer), the Flemish cancer society
License Information

Version of Record valid from 2019-12-20
More Information

Peer Review Statement: The publishing and review policy for this title is described in its Aims & Scope.

Aim & Scope: http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=idrd20

Publication History

Received: 2019-11-08

Accepted: 2019-12-11

Published: 2019-12-20

Document is current